helps to optimise the value of innovation

The value of ‘Net Monetary Benefit’ – Have a look at our most recent blog.

Hebias

Watch corporate movie

Forecast models

Sales flow analysis

Art. 111 - 114

Price dossiers

Interactive Value Tools

Training

Budget Impact dossier

Reimbursement dossiers

Posters & Abstracts

Phase IV study support

Life cycle management

eHealth / mHealth

Data collection

Modelling

Validation of data

Submission activities

Day 0-180

Managed Entry Agreements

P & R strategy

Mapping of sales flow

Literature review

CE analysis

Delphi panels

Data analysis

International KOL boards

CNK code

Gap analysis

Patient flow

Strategy

Trial Protocol

MedTech

Contact us

HEBIAS helps to optimise the value of

MedTech  Pharma  Diagnostics  mHealth

in the    BeNeLux   via tailor made Market Access support:

Strategy & Guidance

How to collect optimal data in the most optimal way? How to avoid post-hoc analyses? Full scope or subgroup? Pricing and submission strategy, project management …

Read more

Data collection

How to collect robust clinical evidence & epidemiology data? Delphi panels or a survey? Targeted or systematic? How should they be validated? …

Read more

Data analysis

How can you select the best data? Sensitivity analysis – Scenario analysis – Subgroup results – Sales flow & forecasting – …

Read more

Price & Reimbursement dossiers

HEBIAS offers ‘A to Z’ market access-related services, including high quality price & reimbursment dossiers, to optimise the value of your innovation for patients, healthcare, society and you.

Read more

Interactive value tools

Interactive digital value tools (iOS, Android, web-based) to demonstrate the added value of your innovation to your stakeholders.

 

Read more

Market Access Activities
—
Health Economics
—
Medical Writing

 

Contact us

Vision

We target the highest possible societal health gain for innovative pharmaceuticals, diagnostic tests and MedTech.

Mission

We provide guidance all the way from the design of clinical studies to the post-launch phase, in addition to the classic market access consultancy services.

Result

HEBIAS helps to bring your innovation to the market in an optimal way.

How?

A well-designed and optimised market access process starts with the right set-up of clinical trials. • HEBIAS helps to indicate which data should be collected, and how economic models should be designed and aligned. This optimises the introduction of your innovation to the market and the conditions to keep it there. • HEBIAS uses a multidisciplinary approach, going beyond the limits of classic market access consultancy.

Contact us